Salmonella typhimurium makes cobalamin (vitamin B 12 ) during anaerobic growth (17) . Most of the cobalamin synthetic genes are organized into a single operon (cob or cbi) mapping at min 41 (3, 18) . The genetic map of the cob operon can be divided into three distinct regions, each of which includes mutations with characteristic phenotypes. Part I has 17 genes (cbi) needed for cobinamide (Cbi) synthesis; strains with mutations in this region (CobI) can synthesize vitamin B 12 when Cbi is provided. Part II of the operon includes mutations that prevent vitamin B 12 synthesis unless 5,6-dimethylbenzimidazole (DMB) is provided (CobII), suggesting that this region contains the genes for DMB synthesis. Part III includes genes for joining Cbi and DMB to produce functional adenosyl-cobalamin (Ado-B 12 ); these mutants (CobIII) cannot make vitamin B 12 even when both DMB and Cbi are provided. The standard view of the pathway is depicted in Fig. 1 .
A fine-structure genetic map of the cob or cbi operon shows that the three types of mutations are ordered as parts I, III, and II in a single operon (3, 18) . The nucleotide sequences of parts I and III have been determined (27) . On the basis of sequence homology to genes of known function in Pseudomonas denitrificans (for a recent review, see reference 2), it has been possible to assign functions to many of the genes in parts I and III of the cob operon. Mutations in the CobIII region have been analyzed genetically and biochemically, demonstrating that the cobU and cobS open reading frames correspond to part III of the genetic map (11, 24, 35) . These two genes have been assigned the functions diagrammed in Fig. 1 . The cobC gene indicated in Fig. 1 was discovered by Charlotte Grabau (13, 14, 26) and was assigned the depicted phosphatase activity by O'Toole et al. (25) . Mutations in part II of the operon were thought to be defective in DMB synthesis and genetic analysis of CobII mutations suggested that this region encodes a single polypeptide with three or four functionally distinct regions (11) . We provide evidence that the CobT protein catalyzes the synthesis of DMB in addition to its demonstrated ability to perform the nicotinate mononucleotide (NaMN): DMB phosphoribosyltransferase reaction.
Riboflavin is the precursor of DMB in propionibacteria (16) and since the Salmonella vitamin B 12 pathway seems similar to that of propionibacteria (32) , riboflavin is likely to be the precursor in S. typhimurium. The conclusions drawn here support predictions made by Renz and coworkers that enzymes involved in synthesizing DMB are likely to be tightly associated with the enzyme that transfers phosphoribose to DMB (16) .
MATERIALS AND METHODS
Bacterial strains and plasmids. All strains used in this study (listed in Table  1 ) are derivatives of S. typhimurium LT2, except for strains LE392 and MC1061 and their derivatives which carry plasmids and are derived from Escherichia coli K-12. Strain MC1061 was used to harbor plasmids, and strain LE392 was used for propagation of phage. Plasmid pPC2 is a derivative of the pACYC184 vector obtained from Bob Weiss and includes a 7.2-kb EcoRI DNA fragment with part II of the Salmonella cob operon. The pKZ vector was kindly provided by Bob Weiss and has a pUC origin. The pKZ plasmids listed in Table 1 Media, growth conditions, and ␤-galactosidase assays. For bacterial culture, the rich medium was nutrient broth (0.8%; Difco) with 85 mM NaCl. The minimal medium was the E medium of Vogel and Bonner (36) . For phage growth, the NZCM medium (21) supplemented with 0.2% maltose was used. The SM buffer (21) was used to store or dilute bacteriophage . For ␤-galactosidase assays, NCE (no citrate E medium) was used with carbon sources at the concentrations described previously (3) . The concentrations of antibiotics and the growth conditions for aerobic and anaerobic culture were described previously (3). The ␤-galactosidase assays were performed as described by Miller (22) .
Cloning of part II of the operon. When efforts to clone part II of the operon by complementation from standard plasmid libraries were unsuccessful, the following approach was used. An oligonucleotide (pr2-1 [5Ј-CCGCCTTCCCGC ATCGATAATAAAA-3Ј]) was chosen on the basis of known sequence in the distal end of part III of the operon just downstream of an EcoRI site (27) . This oligonucleotide was used to probe plaques of a gt7 library obtained from Brian Nichols. This library contains EcoRI fragments of the Salmonella chromosome. A plaque which hybridized to the probe was identified, and phage from this plaque included a 7.2-kb EcoRI fragment. A Southern blot confirmed that this plaque carried an insert derived from part II of the cob operon (see Results). The plasmid pMJ2, constructed by Michael Johnson, contains the 4.2-kb EcoRI-ScaI subfragment which complements CobII mutations. The pKZ subclones were picked from among a pool of shotgun subclones of the sonication subfragments of the 7.2-kb EcoRI fragment.
All molecular manipulations, including Southern blotting, in vitro plaque hybridization, phage isolation and purification, enzyme digestion, and DNA ligation, were performed as described by Maniatis et al. (21) . Only cobT mutations cause a DMB requirement for vitamin B 12 synthesis; thus, we suggest that all CobII reactions may be catalyzed by the CobT protein (see text). The cobB and cobT genes are proposed to provide alternative NaMN:DMB ribosyltransferases. We argue that the CobB enzyme requires a high concentration of DMB (indicated by large print) and the CobT enzyme has a strong affinity for DMB and thus can act with a low concentration of DMB (indicated by small print). (Fig. 2) overlaps the previously known sequence (27) by about 1.86 kb. New sequence was determined by sequencing with universal primers adjacent to the cloning site of plasmid pKZ. The oligonucleotide pr2-1 (described above) was used as a sequencing primer to determine the intersection of the new and old sequence. Custom-made primers were used to obtain the remaining sequences of the EcoRI-ScaI fragment by using pPC2 or pMJ2 as the template. The nucleotide sequences of both strands were determined completely and compiled by the Genetics Computer Group sequence analysis software package (9) .
The dideoxy-chain termination procedure (29) was used for DNA sequencing. All enzymes and chemicals for sequencing were purchased from United States Biochemical Corporation. Routine sequencing was done with Sequenase version 2.0 (United States Biochemical Corporation). Compressions and other ambiguities were resolved with 7-deaza-GTP reactions. Custom-made primers were obtained from Robert Schackmann at the University of Utah Sequence Facility.
PCR and cycle sequencing. Insertion mutations in the CobII region were localized by PCR and cycle sequencing as described previously (7) . Briefly, primers were designed corresponding to the ends of the insertion element and from the CobII region upstream and downstream of the insertion site. Four PCRs were set up with pairwise combinations of primers (one from the insertion element and one from the nearby chromosomal region). The lengths of the PCR products showed the approximate sites of the insertions and the orientations of the insertions. Cycle sequencing was done with the purified PCR products described above; this provided the exact border sequences of the inserts.
Oligonucleotides used for PCRs are listed in Table 2 . MuL and MuR are primers corresponding to the left and right ends of the MudJ element, respectively (15) . Primer T-I corresponds to the 66-bp inverted repeat at both ends of Tn10 (37) . Primers T-L and T-R are unique sequences just inside the element from the 66-bp inverted repeat at the left and right ends of Tn10, respectively. Primers pr2-2, pr2-3, pr2-4, and pr2-5 were designed to match certain sites of the CobII region.
Cloning of the single cobT gene. A single cobT gene was amplified by PCR and cloned into the BglII and EcoRI sites of the plasmid vector pLacPO (constructed by Elliot Altman (1) . This places the gene under the control of the wild-type lac regulatory elements. The DNA polymerase used for PCR cloning of cobT is Pfu, which has a 3Ј-to-5Ј proofreading exonuclease activity and possesses a 12-fold-higher fidelity than that of Taq polymerase (8). Plasmid pMJ2 (described above) was used as the template; PCR was initiated with two oligonucleotide primers: cT-F (5Ј-TACTATAGATCTATGAGCCGATTGTTGCGGACG-3Ј), which has a BglII site (underlined) before the start codon ATG (bold), and primer cT-R (5Ј-ATATATGAATTCTTATGTTGCGTTTGCGTTCCC-3Ј), which has a EcoRI site following the terminator codon TAA (bold). The PCR fragment generated was cut with BglII and EcoRI and ligated between the BglII and EcoRI sites of the pLacPO vector. The PCR-cloned cobT gene was used for complementation tests.
Inserting a kanamycin resistance gene into the chromosome ORF gene. The plasmid pMJ2 which includes the entire gene which we designate ORF was opened at the unique site BstXI located about 250 bp downstream of the start codon. A 1.5-kb DNA fragment which contains a kanamycin resistance gene (10) was inserted at this site, and the plasmid was closed by T4 DNA ligase. This construct was electroporated into strain TT14561 (lacking the host restriction enzyme but able to perform host methylation) and then transduced into S. typhimurium TR6612, a polA mutant that does not support plasmid replication (38) . The kanamycin resistance gene of the plasmid can be inherited only by recombination into the chromosome, using the sequences (3 and 1 kb) which flank the kanamycin resistance gene. Phage lysates from Kn r transformants were used to transduce strain TR6583, selecting Kn r transductants. Linkage analysis showed that the Kn r phenotype is over 96% linked to mutations in the cobT gene. PCR and cycle sequencing confirmed that the Kn r gene is at the BstXI site of the ORF gene.
Identification of Mud-lac fusions in ORF. Many Mud-lac insertions that are linked to cob mutations but show no cob phenotype have been isolated (3). These insertion mutations were screened in search of a Mud-lac fusion to the ORF gene. Of 54 Mud-lac fusions screened, 6 showed over 95% cotransduction with a cobT mutation. Strains with these tightly linked Mud-lac fusions were plated on succinate (1%) 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) plates or glucose (0.2%) X-Gal plates; four showed blue color, suggesting that the inserted lacZ gene was expressed by a chromosomal promoter. Finally, PCR and cycle sequencing showed that three of the identified Mud-lac fusions carried an insertion within the ORF gene and are in the correct orientation for expression by the ORF promoter. The Mud-lac fusions in ORF were used to study regulation of the ORF gene.
Linkage analysis and genetic methods. Linkage of the supD gene to the cobT gene was determined by transduction crosses. The high-frequency generalized transducing phage mutant of phage P22, HT105/1 int-201 (30) was used to produce phage lysates. For all transductional crosses, cells (2 ϫ 10 8 ) and phage (10 7 to 10 8 ) were mixed and incubated nonselectively in NB medium for about 30 to 60 min (to allow expression of donor drug resistance genes) before plating on selective medium. Nonselective green indicator plates were used to purify phagefree transductant clones (6) . The clear-plaque P22 mutant H5 was used to test the phage sensitivity of the purified transductants. Replica printing was performed to score coinheritance of Cob phenotypes with the selected drug resistance.
Nucleotide sequence accession number. The nucleotide sequence reported here has been submitted to GenBank and has been assigned the locus STYCO-BII and the accession number L35477.
RESULTS
Cloning of the CobII region of the cob operon. Phage clones carrying the end of the cob operon were identified by plaque hybridization with a probe whose sequence is at of the distal end of the previously known cob sequence. The insert of this clone extends beyond known cob sequence (see Materials and Methods). Southern hybridization was done to confirm that the fragment includes the promoter-distal end of the cob operon. The cloned 7.2-kb EcoRI fragment was labeled with [␥-32 P]ATP and used for hybridization to EcoRI-digested DNAs from both wild-type and CobII mutant strains (Fig. 3B) . The probe hybridized with a 7.2-kb chromosome fragment from both wild-type cells and from a CobII point mutant (Fig.  3A, lanes 2 and 4) . It hybridized with a smaller fragment of DNA from CobII deletion mutants (Fig. 3A, lanes 1 and 3) . Two hybridizing fragments are seen for each of the CobII:: MudJ insertion mutants (lanes 5 and 6). The MudJ element is about 11.4 kb long and has one EcoRI site. The sizes of these two hybridizing bands add up to about 18.6 kb, the combined size of the insertion element (11.4 kb) and the chromosomal EcoRI fragment (7.2 kb). These results demonstrate that the cloned 7.2-kb fragment includes the CobII region.
Open reading frames in the distal end of the cob operon. The reported sequence data completes the cobT gene. The nucleotide sequence of part of the cobT gene was reported previously (27) , and the first base of the cobT gene is arbitrarily assigned bp 1 in Fig. 4 . The complete cobT gene encodes a 37.8-kDa protein of 367 amino acids. The amino acid sequence can be aligned with the amino acid sequence of the CobU (20) . A partial sequence (35 amino acids) from Klebsiella aerogenes shows 70% identity to ORF (31) . Another partial sequence, reported for Caenorhabditis elegans (GenBank accession number T00301), shows 70% identity over 80 amino acids of reported sequence). The closeness of this match suggests that the sequence reported for C. elegans may actually be derived from a bacterial contaminant.
Downstream of ORF is a palidromic sequence which can be arranged in two alternative conformations (4) . Conformation I has a free energy of Ϫ17.2 kcal/mol and is not followed by a run of U residues; conformation II has a free energy of Ϫ19.9 kcal/mol and is followed by a run of 6 U residues. It seems likely that conformation II may serve to terminate ORF transcripts.
An asparagine tRNA gene is found beyond the terminator of ORF and is transcribed clockwise. The sequence of this tRNA gene is identical to that of the E. coli genes asnU, asnV, and asnT, but the flanking sequences suggest that the gene near cob may correspond to the asnU gene of E. coli (12) .
All insertion mutations with a CobII phenotype affect the cobT gene and are complemented by a minimal cobT plasmid. Detailed genetic mapping and complementation tests of CobII mutations were reported previously (11) . The point mutations in this region of the map are interspersed between insertion mutations that are shown (below) to affect the cobT open reading frame. The complementation data suggested that this region encodes a single protein, since many point mutations failed to complement all other CobII mutations. However, three groups of contiguous point mutations (cobJ, cobK, and cobL) showed intragenic complementation, suggesting that the protein has several independently functional domains (see below).
Four Mud insertion mutations in the CobII region were localized by PCR amplification and precisely mapped by cycle sequencing (Fig. 4) . These four insertions are mixed among point mutations of the four intragenic complementation groups on the genetic map (11) . All known DMB auxotrophic mutations (CobII) map at the distal end of the cob operon, and all those tested affect the cobT open reading frame.
For complementation tests, we have cloned a minimal cobT gene following PCR amplification. Only the coding sequence of the cobT gene was amplified (see Materials and Methods). The cloned cobT gene is expressed by the wild-type lac promoter and is inducible by isopropyl-␤-D-thiogalactopyranoside. When induced, the single cobT gene complements all CobII mutations tested, including a deletion that covers almost the entire genetically defined gene and extends outside the distal end of the operon (strain TT17868). O'Toole and coworkers have demonstrated that clones of the cobU and cobS genes (located promoter proximal to the cobT gene) do not correct the defect of cobT mutations (24) . These results indicate that cobT is the only gene affected by mutations with a CobII phenotype.
Insertion mutations in ORF have no Cob phenotype. To test whether the ORF gene distal to the cobT gene plays a role in vitamin B 12 synthesis, we inserted a kanamycin resistance gene into the ORF and recombined this constructed mutation into the Salmonella chromosome. Under both aerobic and anaerobic conditions, this constructed null mutation does not show any defect in vitamin B 12 synthesis (data not shown).
Furthermore, we have isolated three MudJ insertions in ORF and determined their exact positions by PCR and cycle sequencing. None of these insertions shows a Cob phenotype. The Tn10dTc insertion between the cobT gene and ORF also has no phenotypic defect. These findings indicate that ORF is not essential for vitamin B 12 synthesis.
ORF is not expressed as part of the cob operon. To determine whether ORF is transcribed as part of the cob operon, we assayed the ␤-galactosidase activity of an ORF::lac fusion in cells grown with or without oxygen (Table 3) . Under both aerobic and anaerobic conditions, the ORF gene is constitutively expressed at a basal level (about 15 Miller units) . When propanediol was added, no obvious induction was observed under aerobic conditions in glucose medium. There was a ca. twofold induction by propanediol when cells were grown aerobically in succinate-containing medium and anaerobically in both glucose-and pyruvate-fumarate-containing media. This induction is very low in comparison to the 10-to 20-fold induction seen for a cobT::lac fusion. The weak induction of ORF by propanediol was eliminated by the cobT111::Tn10 insertion, suggesting that there is some read-through of a termination site between the cobT gene and ORF. This is probably a rho-dependent terminator, since no stem-loop structure was detected in the 78-bp interval between the cobT gene and the ORF. The basal level of ORF expression may be due to a promoter located between cobT and a Tn10dTc insertion in the space between the cobT and ORF genes. We suggest this because the zea-3777::Tn10dTc insertion (30 bp upstream of ORF) abolishes all expression of an ORF::lac fusion, but the distal cobT111::Tn10 does not abolish basal ORF expression. No promoters have been found by inspection of the sequence between the cobT and ORF genes.
The supD locus is cotransducible with the cobT gene. The supD (serU) locus encodes a tRNA Ser which can give rise to suppressors of the amber codon UAG (34) . In a serU132 (supD32) mutant of E. coli, the CGA anticodon of wild-type tRNA 2 Ser is replaced by CUA in the suppressor tRNA. In E. coli, the serU gene maps at 43 min (2054 kb), and the asnT gene is located at a similar position (2054 kb). Two extra copies of asparagine tRNA genes (asnU and asnV) are located at 2070 and 2072 kb (19) . The finding that an asparagine tRNA gene (asnU) lies just beyond ORF suggested that the supD locus in S. typhimurium might be closer than suspected from the genetic map (28) . Transductional linkage analysis based on 200 to 300 transductants for each cross is presented in Fig. 6 . The insertion cobT61::MudA is about 5% cotransducible with a supD amber suppressor mutation. A zea-3666::MudF insertion downstream of cobT (80% linked to the cobT gene) showed 14% cotransduction with a Tn10 closely linked to supD.
The conflict between the phenotypes of cobT mutants and the reported activity of the CobT enzyme. The CobT protein has been reported to catalyze the transfer of ribose phosphate from NaMN to DMB to form ␣-ribazole-5Ј-phosphate (35) . The proposed pathway is depicted in Fig. 1 , and the structures of the key molecules are shown in Fig. 7 . A mutant lacking the phosphoribosyltransferase activity ascribed to CobT protein would be expected to show a CobIII phenotype, the inability to make vitamin B 12 even when both DMB and Cbi are provided. Mutants of P. denitrificans lacking the enzyme are unable to make vitamin B 12 even when DMB is provided, suggesting that they have the predicted CobIII phenotype (5). However, Salmonella cobT mutants show a CobII phenotype; they are still able to join Ado-Cbi and DMB to form vitamin B 12 but cannot One explanation of the situation has been offered by Trzebiatowski et al. (35) who propose the existence of a second phosphoribosyltransferase with a very high K m for DMB. The existence of this enzyme would explain why cobT mutants can still join DMB and Ado-Cbi. The DMB requirement of these mutants is explained if the alternative enzyme has a low affinity for DMB and is active only when a very high level of exogenous DMB is provided. Two pieces of evidence support this explanation. (i) A very high concentration of DMB (3 ϫ 10 Ϫ4 M) is required to allow cobT deletion mutants to make vitamin B 12 .
(ii) Trzebiatowski et al. have isolated a mutant (cobB1206:: MudJ) that appears to lack the predicted alternative transferase. That is, the mutation alone has no phenotype, but when added to a strain with a cobT deletion, it converts the CobII phenotype to the CobIII phenotype expected for strains lacking all transferase activity (Fig. 1) . While their explanation is likely to be correct, it raises several questions. Why did not the normal DMB synthetic enzymes create sufficient DMB to activate the alternative enzyme? If cobT is not involved in DMB synthesis, why have no true DMB synthesis mutants been isolated in the exhaustive mutant hunts that have been conducted?
Evidence that the CobT protein has multiple functions. Complementation studies of point mutations with a CobII phenotype indicated that they all affect a single protein; that is, some recessive point mutations failed to complement all other CobII mutations (11) . However, the pattern of intragenic complementation was interesting. Four regions of the gene were distinguished (designated J, K, L, and M). Point mutations in the M region failed to complement all others. Point mutations in the J, K, and L regions failed to complement other mutations in their own region but complemented mutations in the other two groups. These results suggested a protein with four domains of different functions. The J, K, and L regions appear to perform distinct independent functions while the M region is required for all activities. This interpretation of the complementation results is diagrammed in Fig. 8 .
Strains carrying mutations within the cobT gene that are satisfied by a low level of DMB. To pursue this interpretation of the complementation results, we tested strains carrying mutations in each of these regions for their DMB requirement. A representative mutation from each class is shown in Table 4 . Strains with point mutations in regions K and M, like those with deletion mutations, required a high level of DMB (3 ϫ 10 Ϫ4 M) to permit vitamin B 12 synthesis. This was true of all strains with mutations in the M region. Some strains with mutations in the K region were satisfied by 10-fold-less DMB, and one strain with a mutation in the K region (cobT293) required only 3 ϫ 10 Ϫ9 M DMB. It is likely that this mutation is extremely leaky and that all strains with mutations in the K region retain residual phosphoribosyltransferase activity (see below). Surprisingly, all nonpolar point mutations in the J and L regions could make vitamin B 12 when the strains were supplied with a 1,000-fold-lower concentration of exogenous DMB (3 ϫ 10 Ϫ7 M). In general, strains with mutations in the L region appeared to require slightly more DMB than those with mutations in the J region (data not shown). If the high level of DMB required by cobT deletion mutants is needed to activate the alternative enzyme (cobB) as suggested by Trzebiatowski et al. (35) , then the cobT mutants that grow on a low concentra- tion of DMB appear to retain transferase activity but lack some other activity needed for vitamin B 12 synthesis. Since the J and L mutants make vitamin B 12 when a low level of DMB is provided, we suggest that they have lost only the ability to make DMB and that this synthesis is a normal activity of the CobT enzyme. We propose that K mutants have lost only transferase activity while deletions and M point mutants have lost both activities.
Some cobT mutants appear to retain transferase activity and are defective only in DMB synthesis. We tested this possibility further by combining various cobT point mutations with a cobB mutation (generously provided by Jorge Escalante). As reported by Trzebiatowski et al., a cobT deletion mutant (CobII Ϫ ) gained a CobIII phenotype when the cobB mutation (no phenotype alone) was introduced (35) . We confirmed this and found that point mutations in the cobT regions K and M behaved similarly (Table 4) . Double mutants of cobB and mutations in the K region showed a CobIII Ϫ phenotype (failure to grow on Cbi plus DMB) when scored early but were able to develop a CobIII ϩ phenotype later. This is probably due to a partial loss of phosphoribosyltransferase activity. Mutations in the J and L regions retained their CobII phenotype in the presence of a cobB mutation. Their ability to join DMB and Cbi (despite the cobB mutation) suggests that J and L mutants have transferase activity that could not have been provided by the cobB gene. The continued CobII phenotype (DMB requirement) of J and L mutants cannot reflect use of DMB to activate the alternative transferase, since that alternative is eliminated by the cobB mutation. This result demonstrated (if indirectly) that the CobT enzyme can synthesize DMB in addition to its demonstrated transferase activity.
The compound dimethylphenylenediamine (DMPD) (Fig.  7 ) was reported to substitute for DMB in supporting growth of some cobT mutations (11) . We confirmed that the mutants which are fed this compound are those with a lesion in the J or L region, which we concluded had lost only the ability to synthesize DMB. With more time, all cobT mutants were able to grow on DMPD, including those with a deletion of the entire gene. We propose that DMPD is not a synthetic intermediate but is converted to DMB by an alternative route. Apparently, conversion of DMPD produces insufficient DMB to activate the CobB enzyme, so only CobT mutants with normal transferase activity are able to use it well.
DISCUSSION
The distal end of the cob operon, which had not been previously sequenced, includes mutants that can synthesize vitamin B 12 cob-291 deletion 3 ϫ 10 The fact that all mutations with a CobII phenotype affect the cobT gene conflicts in two ways with the biochemically assigned activity of the protein, transfer of phosphoribose from NaMN to DMB to form ␣-ribazole-5Ј-phosphate (5, 35) . First, cobT mutants are still able to join Cbi and DMB, so they must have another enzyme able to perform the phosphoribose transfer (Fig. 1) , and second, they need exogenous DMB to perform this synthesis, suggesting a defect in DMB synthesis. The conflict seems to exist only in S. typhimurium, since mutants of P. denitrificans lacking the homolog of the CobT enzyme are unable to make vitamin B 12 even when DMB is provided. This could be explained if P. denitrificans lacked the CobB alternative phosphoribosyltransferase.
Trzebiatowski and coworkers (35) explained these conflicts by proposing that S. typhimurium produces a second transferase with a high K m for DMB. This would explain the ability of cobT mutants to join Cbi and DMB; the DMB requirement of cobT mutants would be caused by needing a high level of DMB to stimulate the second transferase. They supported their suggestion by isolating mutants (cobB) likely to be defective in the predicted second phosphoribosyltransferase. Double mutants (cobT cobB) are unable to join DMB and Ado-Cbi, consistent with a complete lack of the phophoribosyltransferase. While we think their explanation is correct, it appears to be incomplete. If the CobT enzyme is not involved in DMB synthesis, why have the real DMB synthetic enzymes not been revealed by the exhaustive mutant hunts that have been conducted?
We provide genetic evidence that the cobT enzyme is responsible for DMB synthesis in addition to its transferase activity. Particular alleles of the cobT gene appear to retain transferase activity but still require DMB. Two regions of the cobT gene include mutations that appear to be defective only in DMB synthesis. Since mutations in these two regions complement each other, it is possible that at least two DMB synthetic reactions are catalyzed; this is a minimal estimate, since it depends on the available number of alleles. The failure to isolate CobII mutations mapping to genes other than cobT suggests that the entire synthesis of DMB (probably from riboflavin) is accomplished by the CobT enzyme. Since the CobU protein of P. denitrificans shows sequence similarity to the CobT protein over its entire length, it seems likely that this protein also accomplishes the synthesis of DMB in Pseudomonas species.
The finding that the CobT protein catalyzes both DMB synthesis and transfer of ribose phosphate fulfills a prediction made 15 years ago by Renz and coworkers (16) . On the basis of labeling studies done in propionibacteria, they demonstrated that the two nitrogen atoms in the central ring of riboflavin (Fig. 7) have different probabilities of attachment to the ribose of DMB nucleotide. In free DMB, these two nitrogen atoms are chemically indistinguishable because of the symmetry of DMB (Fig. 7) . Therefore, it would be impossible to maintain preferential attachment of one of these atoms to ribose. This led them to conclude that about 20% of the synthesized DMB is not released as a free intermediate. Renz predicted that the transferase must be associated closely with the DMB synthetic enzyme. That prediction is fulfilled if a single polypeptide is able to catalyze both DMB synthesis and the transferase reaction. Also consistent with this finding is Renz's observation that the synthesis of DMB is stimulated by the addition of nicotinate to the reaction mixture. This suggests that nicotinate (or a derived compound such as NaMN) might allosterically regulate the synthetase. This possibility is easy to visualize if a single protein catalyzes both the synthesis of DMB and the NaMN-dependent transfer of ribose phosphate.
It is remarkable but not unprecedented that a protein of average size (40 kDa) is able to catalyze so many reactions. A hypothetical scheme for DMB synthesis suggested by Renz involves five reactions and the transferase would be a sixth. However, some of the synthetic reactions might occur in a concerted way. The proposed scheme does not include as an intermediate DMPD (which can be used in place of DMB by some cobT mutants). However, a folate-dependent addition of one carbon between the amino groups of DMPD might generate DMB by a means that is independent of the CobT enzyme. An unattractive feature of Renz's proposed pathway is its requirement for molecular oxygen; S. typhimurium can synthesize vitamin B 12 (and therefore DMB) under completely anaerobic conditions.
There are several other multifunctional enzymes in the vitamin B 12 synthetic pathway. Probably most remarkable is the CysG enzyme which methylates two sites on uroporphyrinogen III to form precorrin-2, a precursor of both vitamin B 12 and siroheme. The same CysG polypeptide catalyzes ring oxidation and iron insertion in the synthesis of siroheme (33) . Another bifunctional enzyme is encoded by cobU and catalyzes two sequential reactions (kinase and GDP transferase) in the CobIII part of the pathway (24) (Fig. 1) . A third example may be encoded by the cobC gene, which was discovered by Charlotte Grabau (13, 14, 26, 27) and recently reported to encode a phosphatase for DMB-ribose phosphate, as shown in Fig. 1  (25) . The reported activity predicts a CobIII phenotype for cobC mutations. In fact, these mutants can perform the CobIII reactions but appear blocked prior to cobyric acid in the CobI portion of the pathway. If the reported activity is correct, this protein may also prove to have multiple functions.
A search of the GenBank data base with TFASTA revealed homologs of the CobT and ORF proteins in some other organisms. In E. coli, which lacks the CobI genes, the CobIII and CobII regions are organized in the same way as those of S. typhimurium; E. coli also has an adjacent ORF homolog and an asparagine tRNA gene (20) . In K. aerogenes, a homolog of ORF is found near the nacC (nitrogen assimilation control protein) and there is also an asparagine tRNA gene nearby (31) . It is not known whether the cob genes of K. aerogenes map in this region. The homolog of the cobT gene in R. meliloti is next to the dgkA (diacylglycerol kinase) gene, as it is in P. denitrificans (23) .
In E. coli, one asparagine tRNA gene is located near the serU gene and the other two are about 16 kb away (19) . If S. typhimurium has a similar number of asn tRNA genes, we suppose that asnU and asnV are close together near the cob operon and we have sequenced only the asnU gene; presumably the asnT gene is nearer the serU (supD) gene which is weakly linked to the cobT gene.
